
RESEARCH GRANT AWARDS
AWARDS LIST.
Totals by Year
2024 - 1,139,000
2023 - $891,364
2022 - $1,199,966
2021 - $749,812
2020 - $630,000
2019 - $690,000
2018 - $750,000
2017 - $747,772
2016 - $720,000
2015 - $840,000
2014 - $810,000
2013 - $808,500
2012 - $720,000
2011 - $599,780
2010 - $438,000
2009 - $435,000
2008 - $619,993
2007 - $232,600
2006 - $384,551
Amounts flagged (*) below are funded by Cancer League of Colorado and a generous matching grant from MDC/Richmond American Homes Foundation
Rebecca Schweppe, PhD
Cooperative Src and MAP Kinase Signaling in Thyroid Cancer
$ 30,000
2018
Scott Cramer, PhD and James Costello, PhD
Targeting the Achilles heel of prostate cancer with loss of CHD1 and MAP3K7
$ 60,000
2018
Katja Kiseljak-Vassiliades, DO and Kimberly Jordan, PhD
Potentiating anti-PD1 Immunotherapy with Mitotane in Adrenocortical Carcinoma
$ 60,000
2018
Nicholas Forman, MD
Characterization of heterogeneous tumor subpopulations in childhood ependymoma
$ 30,000
2018
Daniel V. LaBarbera, PhD and Wells A. Messersmith, MD
Patient Derived Tumor Organoids for Personalized and Targeted Colorectal Cancer Therapeutics
60,000
2017
Jung-Jae Lee, PhD
Storable, Thermally Activated, Self-Illuminating Nanoparticles Optical Imaging of Cancer
29,835
2017
Darinee Tippimanchai, PhD
Targeting IL17 in Kras mutant lung cancer
30,000
2017
Jenna Sopfe, MD
Evaluation of Malgylcemia via Continuous Glucose monitoring in the Pediatric Hematopoietic Stem Cell Transplant Population
29,961
2017
John Tentler, PhD
Cancer Research Summer Fellowship Program
30,000
2017
Rebecca Schweppe, PhD
Targeting FAK and Src in Thyroid Cancer
30,000
2017
Matthew J. Sikora, PhD
Exploiting apoptotic vulnerability in anti-estrogen response and resistance in invasive lobular carcinoma
30,000
2017
Jing H. Wang, MD, PhD
Elucidate novel mechanisms of chemotherapy agent-treated lymphomas to activate immune responses
30,000
2017
Kasey Couts, PhD
Improving targeted therapy in melanomas with BRAF fusions
30,000
2017
Britta Jacobsen, PhD
Examining the role of c-Kit in metastasis of Invasive Lobular Breast Cancer
30,000
2017
Eric Clambey, PhD
High-dimensional analysis of effector T cell mechanisms in lung cancer
30,000
2017
Heide L. Ford, PhD
Role of Six2 in mediating late stage metastasis
30,000
2017
Paul Jedlicka, MD, PhD
The epigenetic modifiers PHF2 and PhF8 in Ewing Sarcoma
30,000
2017
Changwei Liu, PhD
Validating USP35 as an anticancer drug target
30,000
2017
Hyunmin Kim, PhD
Systematic Alternative Splicing Analysis for Trancriptomic Misregulation in Cancer
30,000
2017
David Bentley, PhD
Deregulation of mRNA 3′ end formation in breast cancer
30,000
2017
Dan Theodorescu, MD, PhD
Whole genome knockout screening to identify novel TERT regulators with prognostic relevance in bladder cancer patients
30,000
2017
Todd Hankinson, MD, MBA
Comparison of Adult Adamantinomatous Craniopharyngioma Gene Expression with Known Pediatric Gene Expression
27,976
2017
Sana Karam, MD, PhD
Enhancing the Effects of Immune Checkpoint Blockade with Radiation Therapy in Head and Neck Cancer
30,000
2017
Amanda C. Winters, MD, PhD
Validating CD123 as a Leukemia Stem Cell Marker and Therapeutic Target in Pediatric AML
30,000
2017
James Costello, PhD
Measuring chromosome-conformation abnormalities within a single cancer cell
30,000
2017
Traci R. Lyons, PhD and Beth Taburini, PhD
Evaluating the role of pro-lymphangiogenic factor Sem7a in dampening anti-tumor immunity
60,000
2017
James DeGregori, PhD
Understanding how smoking alters selection for common oncogenic mutations in the genesis of lung cancer
30,000
2017
Isabel Schlaepfer, PhD
Role of androgens on lipid catabolism in prostate cancer
30,000
2016
Scott Alper, PhD and Daniel Pollyea, MD, MS
Splicing gene mutations and infection in MDS patients
30,000
2016
Lauren Fishbein, MD, PhD
Investigating the role of MAML3 in neuroendocrine tumorigenesis
30,000
2016
Melanie Vincent, PhD
Targeting Eya2 to inhibit c-Myc driven Medulloblastoma Tumor
30,000
2016
William Robinson, MD, PhD
CARD10 and NFkB signaling in melanoma: Implications for immunotherapy
30,000
2016
S. Gail Eckhardt, MD & Aik Choon Tan, PhD
Exploiting Patient Derived Cancer Models for Novel Immunotherapy Regimens
60,000
2016
Lynn Heasley, PhD and Raphael Nemenoff, PhD
Identification of TME-Derived Pathways for Co-Targeting in FGFR1-Dependent Lung Cancers
60,000
2016
Howard Li, MD
Mechanisms of Resistance to T Cell-Mediated Immunotherapy in Non-Small Cell Lung Cancer
30,000
2016
Christian Young, PhD
Targeting paracrine stromal factors induced by P13K inhibitor therapy in head and neck cancer
30,000
2016
Yuwen Zhu, PhD
Targeting the novel immune checkpoint CD112R for cancer therapy
30,000
2016
Dohun Pyeon, PhD
Role of Antitumor Chemokines in Clearance of Head and Neck Cancer
30,000
2016
Diana Cittelly, PhD
Role of TRKB/BDNF axis in brain metastatic breast cancer
30,000
2016
Shi-Long Lu, PhD and John Song, MD
Role of microRNA methylation and its application as a biomarker in head and neck cancer
60,000
2016
James DeGregori, PhD
Examining oncogenic clonal expansions in the context of aging
30,000
2016
Arthur Gutierrez-Hartman, MD
Elucidating the Mechanism by which ESE-1 Controls Estrogen Mediated Tumorigenesis in HER2 + ER + Luminal B Human Breast Cancer
30,000
2016
John Tentler, PhD
Cancer Research Summer Fellowship Program
30,000
2016
Joseph Sottnik, PhD
Therapeutic targeting of organ specific tumor growth and metastases through functional genomics
30,000
2016
Matthew Galbraith, PhD
Novel genes mediating cancer cell survival and proliferation in hypoxic conditions
30,000
2016
Christopher Porter, MD
The Role of ETV6 in B lymphopoiesis
30,000
2016
Tamara Terzian, PhD
p53 in melanoma
30,000
2016
Britta Jacobsen, PhD
Examining the role of Mucin-2 in breast cancer
30,000
2016
James Costello, PhD
Integrating Transcriptional Regulatory And Metabolic Networks To Characterize Bladder Cancer Cellular Response to Chemotherapies
$30,000
2015
Neil Box
Determining the utility of UV photography as a quantitative tool for evaluating sun exposure history of children and adolescents
$60,000
2015
John Tentler, PhD
Cancer Research Summer Fellowship Program
30,000
2015
Mayumi Fujita, MD, PhD
Homozygously deleted chromosomal changes in metastatic melanoma
$60,000
2015
Raul Torres, PhD
Tumor-derived LPA immune suppression of CD8 T cell tumor immunity
$30,000
2015
Elizabeth Wellberg, PhD
The role of the Androgen Receptor in obesity-associated postmenopausal breast cancer
$30,000
2015
Anna Capasso, MD
Combination Therapies for Young Patients with late state colorectal cancer
$30,000
2015
Dr. MoumitaGhosh
A novel preclinical model to test Iloprost and PPAR delta antagonist in lung cancer chemoprevention
$30,000
2015
Sana Karam, MD, PhD
Role of EphB4 in radiosensitization in PDX model of head and neck cancer
$30,000
2015
Dan Theodorescu
Identification and characterization of GON4L as a novel regulator of oncogene CD24 in bladder cancer
$30,000
2015
Robert Annett, PhD
Novel Assessment of Neuropsychological Difficulties in Children (NAND-Child)
$60,000
2015
Steve Anderson, PhD
Targeting breast cancer stem cells by inhibiting glucose metabolism
$60,000
2015
Elan Eisenmesser, PhD
The anti-cancer mechanism of Il-37
$30,000
2015
Laurel L. Lenz, PhD
Activation of NK cells for immunotherapy of lung tumors
$30,000
2015
Jennifer Hintzsche, PhD
Identifying Molecular Targets in Melanoma Resistant to Braf/Mek Combination Therapy
$30,000
2015
Margaret Wierman, MD
Role of Mammalian Sterile 20 like kinase 4 (MSTA) in Pediatric Brain Cancer
$60,000
2015
Katja Kiseljak-Vassiliades, DO
Approaches to Targeted Therapy in Adrenal Carcinogenesis
$60,000
2015
Karen Ryall, PhD
Systems analysis of EGFR-inhibitor induced kinome reprograming and EMT in non-small cell lung cancer
30,000
2015
Andrew Thorburn, PhD
Selective targeting of drug-induced autophagy to improve cancer therapy
$ 60,000
2015
MarkGregory, PhD
Redox-targeted therapy for the treatment of FLT3 mutated leukemia
$30,000
2015
Jeffery Kieft, PhD
How does miRNA modulation of mRNA structure regulate production of a pro-tumor chemokine receptor?
$30,000
2015
Christopher Porter, MD/ Jill Slansky, PhD
Leukemia-cell Calcineurin as a central mediator of immune evasion
$60,000
2014
Maranke Koster, PhD
Consequences of TP63 loss on human skin squamous cell carcinogenesis
$30,000
2014
John Tentler, PhD
Cancer Research Summer Fellowship Program
$30,000
2014
Jing Hong Wang, PhD
A Novel Approach to Reveal the Impact of Genetic Mutations on Cancer Genome Stability
$30,000
2014
James Hagman, PhD
Functional analysis of EBF1:PDGFRB, a novel oncoprotein
$30,000
2014
Carol Sartorius, PhD
Quiescent estrogen receptor positive cells as a source of breast cancer recurrence
$30,000
2014
